Global Infant and Child Multiple Vaccine Supply, Demand and Key Producers, 2023-2029
The global Infant and Child Multiple Vaccine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
The process of upgrading global multi-vaccine products is a process of solidifying the competitive landscape.
This report studies the global Infant and Child Multiple Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Infant and Child Multiple Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Infant and Child Multiple Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Infant and Child Multiple Vaccine total production and demand, 2018-2029, (M Doses)
Global Infant and Child Multiple Vaccine total production value, 2018-2029, (USD Million)
Global Infant and Child Multiple Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (M Doses)
Global Infant and Child Multiple Vaccine consumption by region & country, CAGR, 2018-2029 & (M Doses)
U.S. VS China: Infant and Child Multiple Vaccine domestic production, consumption, key domestic manufacturers and share
Global Infant and Child Multiple Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (M Doses)
Global Infant and Child Multiple Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (M Doses)
Global Infant and Child Multiple Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (M Doses).
This reports profiles key players in the global Infant and Child Multiple Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, GSK, Mitsubishi Tanabe Pharma, KM Biologics, Wuhan Institute of Biological Products, Walvax Biotechnology, Chengdu Institute of Biological Products and Minhai Biotechnology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Infant and Child Multiple Vaccine market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (M Doses) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Infant and Child Multiple Vaccine Market, By Region:
1. How big is the global Infant and Child Multiple Vaccine market?
2. What is the demand of the global Infant and Child Multiple Vaccine market?
3. What is the year over year growth of the global Infant and Child Multiple Vaccine market?
4. What is the production and production value of the global Infant and Child Multiple Vaccine market?
5. Who are the key producers in the global Infant and Child Multiple Vaccine market?
The process of upgrading global multi-vaccine products is a process of solidifying the competitive landscape.
This report studies the global Infant and Child Multiple Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Infant and Child Multiple Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Infant and Child Multiple Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Infant and Child Multiple Vaccine total production and demand, 2018-2029, (M Doses)
Global Infant and Child Multiple Vaccine total production value, 2018-2029, (USD Million)
Global Infant and Child Multiple Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (M Doses)
Global Infant and Child Multiple Vaccine consumption by region & country, CAGR, 2018-2029 & (M Doses)
U.S. VS China: Infant and Child Multiple Vaccine domestic production, consumption, key domestic manufacturers and share
Global Infant and Child Multiple Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (M Doses)
Global Infant and Child Multiple Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (M Doses)
Global Infant and Child Multiple Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (M Doses).
This reports profiles key players in the global Infant and Child Multiple Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, GSK, Mitsubishi Tanabe Pharma, KM Biologics, Wuhan Institute of Biological Products, Walvax Biotechnology, Chengdu Institute of Biological Products and Minhai Biotechnology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Infant and Child Multiple Vaccine market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (M Doses) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Infant and Child Multiple Vaccine Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Pentavalent Vaccine
- Quadruple Vaccine
- Triple Vaccine
- Others
- 12 Months Below
- 12 Months Above
- Sanofi
- GSK
- Mitsubishi Tanabe Pharma
- KM Biologics
- Wuhan Institute of Biological Products
- Walvax Biotechnology
- Chengdu Institute of Biological Products
- Minhai Biotechnology
1. How big is the global Infant and Child Multiple Vaccine market?
2. What is the demand of the global Infant and Child Multiple Vaccine market?
3. What is the year over year growth of the global Infant and Child Multiple Vaccine market?
4. What is the production and production value of the global Infant and Child Multiple Vaccine market?
5. Who are the key producers in the global Infant and Child Multiple Vaccine market?
1 SUPPLY SUMMARY
1.1 Infant and Child Multiple Vaccine Introduction
1.2 World Infant and Child Multiple Vaccine Supply & Forecast
1.2.1 World Infant and Child Multiple Vaccine Production Value (2018 & 2022 & 2029)
1.2.2 World Infant and Child Multiple Vaccine Production (2018-2029)
1.2.3 World Infant and Child Multiple Vaccine Pricing Trends (2018-2029)
1.3 World Infant and Child Multiple Vaccine Production by Region (Based on Production Site)
1.3.1 World Infant and Child Multiple Vaccine Production Value by Region (2018-2029)
1.3.2 World Infant and Child Multiple Vaccine Production by Region (2018-2029)
1.3.3 World Infant and Child Multiple Vaccine Average Price by Region (2018-2029)
1.3.4 North America Infant and Child Multiple Vaccine Production (2018-2029)
1.3.5 Europe Infant and Child Multiple Vaccine Production (2018-2029)
1.3.6 China Infant and Child Multiple Vaccine Production (2018-2029)
1.3.7 Japan Infant and Child Multiple Vaccine Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Infant and Child Multiple Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Infant and Child Multiple Vaccine Major Market Trends
2 DEMAND SUMMARY
2.1 World Infant and Child Multiple Vaccine Demand (2018-2029)
2.2 World Infant and Child Multiple Vaccine Consumption by Region
2.2.1 World Infant and Child Multiple Vaccine Consumption by Region (2018-2023)
2.2.2 World Infant and Child Multiple Vaccine Consumption Forecast by Region (2024-2029)
2.3 United States Infant and Child Multiple Vaccine Consumption (2018-2029)
2.4 China Infant and Child Multiple Vaccine Consumption (2018-2029)
2.5 Europe Infant and Child Multiple Vaccine Consumption (2018-2029)
2.6 Japan Infant and Child Multiple Vaccine Consumption (2018-2029)
2.7 South Korea Infant and Child Multiple Vaccine Consumption (2018-2029)
2.8 ASEAN Infant and Child Multiple Vaccine Consumption (2018-2029)
2.9 India Infant and Child Multiple Vaccine Consumption (2018-2029)
3 WORLD INFANT AND CHILD MULTIPLE VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Infant and Child Multiple Vaccine Production Value by Manufacturer (2018-2023)
3.2 World Infant and Child Multiple Vaccine Production by Manufacturer (2018-2023)
3.3 World Infant and Child Multiple Vaccine Average Price by Manufacturer (2018-2023)
3.4 Infant and Child Multiple Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Infant and Child Multiple Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Infant and Child Multiple Vaccine in 2022
3.5.3 Global Concentration Ratios (CR8) for Infant and Child Multiple Vaccine in 2022
3.6 Infant and Child Multiple Vaccine Market: Overall Company Footprint Analysis
3.6.1 Infant and Child Multiple Vaccine Market: Region Footprint
3.6.2 Infant and Child Multiple Vaccine Market: Company Product Type Footprint
3.6.3 Infant and Child Multiple Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Infant and Child Multiple Vaccine Production Value Comparison
4.1.1 United States VS China: Infant and Child Multiple Vaccine Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Infant and Child Multiple Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Infant and Child Multiple Vaccine Production Comparison
4.2.1 United States VS China: Infant and Child Multiple Vaccine Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Infant and Child Multiple Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Infant and Child Multiple Vaccine Consumption Comparison
4.3.1 United States VS China: Infant and Child Multiple Vaccine Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Infant and Child Multiple Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Infant and Child Multiple Vaccine Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Infant and Child Multiple Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Infant and Child Multiple Vaccine Production Value (2018-2023)
4.4.3 United States Based Manufacturers Infant and Child Multiple Vaccine Production (2018-2023)
4.5 China Based Infant and Child Multiple Vaccine Manufacturers and Market Share
4.5.1 China Based Infant and Child Multiple Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Infant and Child Multiple Vaccine Production Value (2018-2023)
4.5.3 China Based Manufacturers Infant and Child Multiple Vaccine Production (2018-2023)
4.6 Rest of World Based Infant and Child Multiple Vaccine Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Infant and Child Multiple Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Infant and Child Multiple Vaccine Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Infant and Child Multiple Vaccine Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Infant and Child Multiple Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Pentavalent Vaccine
5.2.2 Quadruple Vaccine
5.2.3 Triple Vaccine
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Infant and Child Multiple Vaccine Production by Type (2018-2029)
5.3.2 World Infant and Child Multiple Vaccine Production Value by Type (2018-2029)
5.3.3 World Infant and Child Multiple Vaccine Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Infant and Child Multiple Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 12 Months Below
6.2.2 12 Months Above
6.3 Market Segment by Application
6.3.1 World Infant and Child Multiple Vaccine Production by Application (2018-2029)
6.3.2 World Infant and Child Multiple Vaccine Production Value by Application (2018-2029)
6.3.3 World Infant and Child Multiple Vaccine Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Sanofi
7.1.1 Sanofi Details
7.1.2 Sanofi Major Business
7.1.3 Sanofi Infant and Child Multiple Vaccine Product and Services
7.1.4 Sanofi Infant and Child Multiple Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Sanofi Recent Developments/Updates
7.1.6 Sanofi Competitive Strengths & Weaknesses
7.2 GSK
7.2.1 GSK Details
7.2.2 GSK Major Business
7.2.3 GSK Infant and Child Multiple Vaccine Product and Services
7.2.4 GSK Infant and Child Multiple Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 GSK Recent Developments/Updates
7.2.6 GSK Competitive Strengths & Weaknesses
7.3 Mitsubishi Tanabe Pharma
7.3.1 Mitsubishi Tanabe Pharma Details
7.3.2 Mitsubishi Tanabe Pharma Major Business
7.3.3 Mitsubishi Tanabe Pharma Infant and Child Multiple Vaccine Product and Services
7.3.4 Mitsubishi Tanabe Pharma Infant and Child Multiple Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
7.3.6 Mitsubishi Tanabe Pharma Competitive Strengths & Weaknesses
7.4 KM Biologics
7.4.1 KM Biologics Details
7.4.2 KM Biologics Major Business
7.4.3 KM Biologics Infant and Child Multiple Vaccine Product and Services
7.4.4 KM Biologics Infant and Child Multiple Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 KM Biologics Recent Developments/Updates
7.4.6 KM Biologics Competitive Strengths & Weaknesses
7.5 Wuhan Institute of Biological Products
7.5.1 Wuhan Institute of Biological Products Details
7.5.2 Wuhan Institute of Biological Products Major Business
7.5.3 Wuhan Institute of Biological Products Infant and Child Multiple Vaccine Product and Services
7.5.4 Wuhan Institute of Biological Products Infant and Child Multiple Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Wuhan Institute of Biological Products Recent Developments/Updates
7.5.6 Wuhan Institute of Biological Products Competitive Strengths & Weaknesses
7.6 Walvax Biotechnology
7.6.1 Walvax Biotechnology Details
7.6.2 Walvax Biotechnology Major Business
7.6.3 Walvax Biotechnology Infant and Child Multiple Vaccine Product and Services
7.6.4 Walvax Biotechnology Infant and Child Multiple Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Walvax Biotechnology Recent Developments/Updates
7.6.6 Walvax Biotechnology Competitive Strengths & Weaknesses
7.7 Chengdu Institute of Biological Products
7.7.1 Chengdu Institute of Biological Products Details
7.7.2 Chengdu Institute of Biological Products Major Business
7.7.3 Chengdu Institute of Biological Products Infant and Child Multiple Vaccine Product and Services
7.7.4 Chengdu Institute of Biological Products Infant and Child Multiple Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Chengdu Institute of Biological Products Recent Developments/Updates
7.7.6 Chengdu Institute of Biological Products Competitive Strengths & Weaknesses
7.8 Minhai Biotechnology
7.8.1 Minhai Biotechnology Details
7.8.2 Minhai Biotechnology Major Business
7.8.3 Minhai Biotechnology Infant and Child Multiple Vaccine Product and Services
7.8.4 Minhai Biotechnology Infant and Child Multiple Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Minhai Biotechnology Recent Developments/Updates
7.8.6 Minhai Biotechnology Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Infant and Child Multiple Vaccine Industry Chain
8.2 Infant and Child Multiple Vaccine Upstream Analysis
8.2.1 Infant and Child Multiple Vaccine Core Raw Materials
8.2.2 Main Manufacturers of Infant and Child Multiple Vaccine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Infant and Child Multiple Vaccine Production Mode
8.6 Infant and Child Multiple Vaccine Procurement Model
8.7 Infant and Child Multiple Vaccine Industry Sales Model and Sales Channels
8.7.1 Infant and Child Multiple Vaccine Sales Model
8.7.2 Infant and Child Multiple Vaccine Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Infant and Child Multiple Vaccine Introduction
1.2 World Infant and Child Multiple Vaccine Supply & Forecast
1.2.1 World Infant and Child Multiple Vaccine Production Value (2018 & 2022 & 2029)
1.2.2 World Infant and Child Multiple Vaccine Production (2018-2029)
1.2.3 World Infant and Child Multiple Vaccine Pricing Trends (2018-2029)
1.3 World Infant and Child Multiple Vaccine Production by Region (Based on Production Site)
1.3.1 World Infant and Child Multiple Vaccine Production Value by Region (2018-2029)
1.3.2 World Infant and Child Multiple Vaccine Production by Region (2018-2029)
1.3.3 World Infant and Child Multiple Vaccine Average Price by Region (2018-2029)
1.3.4 North America Infant and Child Multiple Vaccine Production (2018-2029)
1.3.5 Europe Infant and Child Multiple Vaccine Production (2018-2029)
1.3.6 China Infant and Child Multiple Vaccine Production (2018-2029)
1.3.7 Japan Infant and Child Multiple Vaccine Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Infant and Child Multiple Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Infant and Child Multiple Vaccine Major Market Trends
2 DEMAND SUMMARY
2.1 World Infant and Child Multiple Vaccine Demand (2018-2029)
2.2 World Infant and Child Multiple Vaccine Consumption by Region
2.2.1 World Infant and Child Multiple Vaccine Consumption by Region (2018-2023)
2.2.2 World Infant and Child Multiple Vaccine Consumption Forecast by Region (2024-2029)
2.3 United States Infant and Child Multiple Vaccine Consumption (2018-2029)
2.4 China Infant and Child Multiple Vaccine Consumption (2018-2029)
2.5 Europe Infant and Child Multiple Vaccine Consumption (2018-2029)
2.6 Japan Infant and Child Multiple Vaccine Consumption (2018-2029)
2.7 South Korea Infant and Child Multiple Vaccine Consumption (2018-2029)
2.8 ASEAN Infant and Child Multiple Vaccine Consumption (2018-2029)
2.9 India Infant and Child Multiple Vaccine Consumption (2018-2029)
3 WORLD INFANT AND CHILD MULTIPLE VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Infant and Child Multiple Vaccine Production Value by Manufacturer (2018-2023)
3.2 World Infant and Child Multiple Vaccine Production by Manufacturer (2018-2023)
3.3 World Infant and Child Multiple Vaccine Average Price by Manufacturer (2018-2023)
3.4 Infant and Child Multiple Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Infant and Child Multiple Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Infant and Child Multiple Vaccine in 2022
3.5.3 Global Concentration Ratios (CR8) for Infant and Child Multiple Vaccine in 2022
3.6 Infant and Child Multiple Vaccine Market: Overall Company Footprint Analysis
3.6.1 Infant and Child Multiple Vaccine Market: Region Footprint
3.6.2 Infant and Child Multiple Vaccine Market: Company Product Type Footprint
3.6.3 Infant and Child Multiple Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Infant and Child Multiple Vaccine Production Value Comparison
4.1.1 United States VS China: Infant and Child Multiple Vaccine Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Infant and Child Multiple Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Infant and Child Multiple Vaccine Production Comparison
4.2.1 United States VS China: Infant and Child Multiple Vaccine Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Infant and Child Multiple Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Infant and Child Multiple Vaccine Consumption Comparison
4.3.1 United States VS China: Infant and Child Multiple Vaccine Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Infant and Child Multiple Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Infant and Child Multiple Vaccine Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Infant and Child Multiple Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Infant and Child Multiple Vaccine Production Value (2018-2023)
4.4.3 United States Based Manufacturers Infant and Child Multiple Vaccine Production (2018-2023)
4.5 China Based Infant and Child Multiple Vaccine Manufacturers and Market Share
4.5.1 China Based Infant and Child Multiple Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Infant and Child Multiple Vaccine Production Value (2018-2023)
4.5.3 China Based Manufacturers Infant and Child Multiple Vaccine Production (2018-2023)
4.6 Rest of World Based Infant and Child Multiple Vaccine Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Infant and Child Multiple Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Infant and Child Multiple Vaccine Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Infant and Child Multiple Vaccine Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Infant and Child Multiple Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Pentavalent Vaccine
5.2.2 Quadruple Vaccine
5.2.3 Triple Vaccine
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Infant and Child Multiple Vaccine Production by Type (2018-2029)
5.3.2 World Infant and Child Multiple Vaccine Production Value by Type (2018-2029)
5.3.3 World Infant and Child Multiple Vaccine Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Infant and Child Multiple Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 12 Months Below
6.2.2 12 Months Above
6.3 Market Segment by Application
6.3.1 World Infant and Child Multiple Vaccine Production by Application (2018-2029)
6.3.2 World Infant and Child Multiple Vaccine Production Value by Application (2018-2029)
6.3.3 World Infant and Child Multiple Vaccine Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Sanofi
7.1.1 Sanofi Details
7.1.2 Sanofi Major Business
7.1.3 Sanofi Infant and Child Multiple Vaccine Product and Services
7.1.4 Sanofi Infant and Child Multiple Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Sanofi Recent Developments/Updates
7.1.6 Sanofi Competitive Strengths & Weaknesses
7.2 GSK
7.2.1 GSK Details
7.2.2 GSK Major Business
7.2.3 GSK Infant and Child Multiple Vaccine Product and Services
7.2.4 GSK Infant and Child Multiple Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 GSK Recent Developments/Updates
7.2.6 GSK Competitive Strengths & Weaknesses
7.3 Mitsubishi Tanabe Pharma
7.3.1 Mitsubishi Tanabe Pharma Details
7.3.2 Mitsubishi Tanabe Pharma Major Business
7.3.3 Mitsubishi Tanabe Pharma Infant and Child Multiple Vaccine Product and Services
7.3.4 Mitsubishi Tanabe Pharma Infant and Child Multiple Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
7.3.6 Mitsubishi Tanabe Pharma Competitive Strengths & Weaknesses
7.4 KM Biologics
7.4.1 KM Biologics Details
7.4.2 KM Biologics Major Business
7.4.3 KM Biologics Infant and Child Multiple Vaccine Product and Services
7.4.4 KM Biologics Infant and Child Multiple Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 KM Biologics Recent Developments/Updates
7.4.6 KM Biologics Competitive Strengths & Weaknesses
7.5 Wuhan Institute of Biological Products
7.5.1 Wuhan Institute of Biological Products Details
7.5.2 Wuhan Institute of Biological Products Major Business
7.5.3 Wuhan Institute of Biological Products Infant and Child Multiple Vaccine Product and Services
7.5.4 Wuhan Institute of Biological Products Infant and Child Multiple Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Wuhan Institute of Biological Products Recent Developments/Updates
7.5.6 Wuhan Institute of Biological Products Competitive Strengths & Weaknesses
7.6 Walvax Biotechnology
7.6.1 Walvax Biotechnology Details
7.6.2 Walvax Biotechnology Major Business
7.6.3 Walvax Biotechnology Infant and Child Multiple Vaccine Product and Services
7.6.4 Walvax Biotechnology Infant and Child Multiple Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Walvax Biotechnology Recent Developments/Updates
7.6.6 Walvax Biotechnology Competitive Strengths & Weaknesses
7.7 Chengdu Institute of Biological Products
7.7.1 Chengdu Institute of Biological Products Details
7.7.2 Chengdu Institute of Biological Products Major Business
7.7.3 Chengdu Institute of Biological Products Infant and Child Multiple Vaccine Product and Services
7.7.4 Chengdu Institute of Biological Products Infant and Child Multiple Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Chengdu Institute of Biological Products Recent Developments/Updates
7.7.6 Chengdu Institute of Biological Products Competitive Strengths & Weaknesses
7.8 Minhai Biotechnology
7.8.1 Minhai Biotechnology Details
7.8.2 Minhai Biotechnology Major Business
7.8.3 Minhai Biotechnology Infant and Child Multiple Vaccine Product and Services
7.8.4 Minhai Biotechnology Infant and Child Multiple Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Minhai Biotechnology Recent Developments/Updates
7.8.6 Minhai Biotechnology Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Infant and Child Multiple Vaccine Industry Chain
8.2 Infant and Child Multiple Vaccine Upstream Analysis
8.2.1 Infant and Child Multiple Vaccine Core Raw Materials
8.2.2 Main Manufacturers of Infant and Child Multiple Vaccine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Infant and Child Multiple Vaccine Production Mode
8.6 Infant and Child Multiple Vaccine Procurement Model
8.7 Infant and Child Multiple Vaccine Industry Sales Model and Sales Channels
8.7.1 Infant and Child Multiple Vaccine Sales Model
8.7.2 Infant and Child Multiple Vaccine Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Infant and Child Multiple Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Infant and Child Multiple Vaccine Production Value by Region (2018-2023) & (USD Million)
Table 3. World Infant and Child Multiple Vaccine Production Value by Region (2024-2029) & (USD Million)
Table 4. World Infant and Child Multiple Vaccine Production Value Market Share by Region (2018-2023)
Table 5. World Infant and Child Multiple Vaccine Production Value Market Share by Region (2024-2029)
Table 6. World Infant and Child Multiple Vaccine Production by Region (2018-2023) & (M Doses)
Table 7. World Infant and Child Multiple Vaccine Production by Region (2024-2029) & (M Doses)
Table 8. World Infant and Child Multiple Vaccine Production Market Share by Region (2018-2023)
Table 9. World Infant and Child Multiple Vaccine Production Market Share by Region (2024-2029)
Table 10. World Infant and Child Multiple Vaccine Average Price by Region (2018-2023) & (US$/Dose)
Table 11. World Infant and Child Multiple Vaccine Average Price by Region (2024-2029) & (US$/Dose)
Table 12. Infant and Child Multiple Vaccine Major Market Trends
Table 13. World Infant and Child Multiple Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (M Doses)
Table 14. World Infant and Child Multiple Vaccine Consumption by Region (2018-2023) & (M Doses)
Table 15. World Infant and Child Multiple Vaccine Consumption Forecast by Region (2024-2029) & (M Doses)
Table 16. World Infant and Child Multiple Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Infant and Child Multiple Vaccine Producers in 2022
Table 18. World Infant and Child Multiple Vaccine Production by Manufacturer (2018-2023) & (M Doses)
Table 19. Production Market Share of Key Infant and Child Multiple Vaccine Producers in 2022
Table 20. World Infant and Child Multiple Vaccine Average Price by Manufacturer (2018-2023) & (US$/Dose)
Table 21. Global Infant and Child Multiple Vaccine Company Evaluation Quadrant
Table 22. World Infant and Child Multiple Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Infant and Child Multiple Vaccine Production Site of Key Manufacturer
Table 24. Infant and Child Multiple Vaccine Market: Company Product Type Footprint
Table 25. Infant and Child Multiple Vaccine Market: Company Product Application Footprint
Table 26. Infant and Child Multiple Vaccine Competitive Factors
Table 27. Infant and Child Multiple Vaccine New Entrant and Capacity Expansion Plans
Table 28. Infant and Child Multiple Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Infant and Child Multiple Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Infant and Child Multiple Vaccine Production Comparison, (2018 & 2022 & 2029) & (M Doses)
Table 31. United States VS China Infant and Child Multiple Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (M Doses)
Table 32. United States Based Infant and Child Multiple Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Infant and Child Multiple Vaccine Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Infant and Child Multiple Vaccine Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Infant and Child Multiple Vaccine Production (2018-2023) & (M Doses)
Table 36. United States Based Manufacturers Infant and Child Multiple Vaccine Production Market Share (2018-2023)
Table 37. China Based Infant and Child Multiple Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Infant and Child Multiple Vaccine Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Infant and Child Multiple Vaccine Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Infant and Child Multiple Vaccine Production (2018-2023) & (M Doses)
Table 41. China Based Manufacturers Infant and Child Multiple Vaccine Production Market Share (2018-2023)
Table 42. Rest of World Based Infant and Child Multiple Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Infant and Child Multiple Vaccine Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Infant and Child Multiple Vaccine Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Infant and Child Multiple Vaccine Production (2018-2023) & (M Doses)
Table 46. Rest of World Based Manufacturers Infant and Child Multiple Vaccine Production Market Share (2018-2023)
Table 47. World Infant and Child Multiple Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Infant and Child Multiple Vaccine Production by Type (2018-2023) & (M Doses)
Table 49. World Infant and Child Multiple Vaccine Production by Type (2024-2029) & (M Doses)
Table 50. World Infant and Child Multiple Vaccine Production Value by Type (2018-2023) & (USD Million)
Table 51. World Infant and Child Multiple Vaccine Production Value by Type (2024-2029) & (USD Million)
Table 52. World Infant and Child Multiple Vaccine Average Price by Type (2018-2023) & (US$/Dose)
Table 53. World Infant and Child Multiple Vaccine Average Price by Type (2024-2029) & (US$/Dose)
Table 54. World Infant and Child Multiple Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Infant and Child Multiple Vaccine Production by Application (2018-2023) & (M Doses)
Table 56. World Infant and Child Multiple Vaccine Production by Application (2024-2029) & (M Doses)
Table 57. World Infant and Child Multiple Vaccine Production Value by Application (2018-2023) & (USD Million)
Table 58. World Infant and Child Multiple Vaccine Production Value by Application (2024-2029) & (USD Million)
Table 59. World Infant and Child Multiple Vaccine Average Price by Application (2018-2023) & (US$/Dose)
Table 60. World Infant and Child Multiple Vaccine Average Price by Application (2024-2029) & (US$/Dose)
Table 61. Sanofi Basic Information, Manufacturing Base and Competitors
Table 62. Sanofi Major Business
Table 63. Sanofi Infant and Child Multiple Vaccine Product and Services
Table 64. Sanofi Infant and Child Multiple Vaccine Production (M Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Sanofi Recent Developments/Updates
Table 66. Sanofi Competitive Strengths & Weaknesses
Table 67. GSK Basic Information, Manufacturing Base and Competitors
Table 68. GSK Major Business
Table 69. GSK Infant and Child Multiple Vaccine Product and Services
Table 70. GSK Infant and Child Multiple Vaccine Production (M Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. GSK Recent Developments/Updates
Table 72. GSK Competitive Strengths & Weaknesses
Table 73. Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base and Competitors
Table 74. Mitsubishi Tanabe Pharma Major Business
Table 75. Mitsubishi Tanabe Pharma Infant and Child Multiple Vaccine Product and Services
Table 76. Mitsubishi Tanabe Pharma Infant and Child Multiple Vaccine Production (M Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Mitsubishi Tanabe Pharma Recent Developments/Updates
Table 78. Mitsubishi Tanabe Pharma Competitive Strengths & Weaknesses
Table 79. KM Biologics Basic Information, Manufacturing Base and Competitors
Table 80. KM Biologics Major Business
Table 81. KM Biologics Infant and Child Multiple Vaccine Product and Services
Table 82. KM Biologics Infant and Child Multiple Vaccine Production (M Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. KM Biologics Recent Developments/Updates
Table 84. KM Biologics Competitive Strengths & Weaknesses
Table 85. Wuhan Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 86. Wuhan Institute of Biological Products Major Business
Table 87. Wuhan Institute of Biological Products Infant and Child Multiple Vaccine Product and Services
Table 88. Wuhan Institute of Biological Products Infant and Child Multiple Vaccine Production (M Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Wuhan Institute of Biological Products Recent Developments/Updates
Table 90. Wuhan Institute of Biological Products Competitive Strengths & Weaknesses
Table 91. Walvax Biotechnology Basic Information, Manufacturing Base and Competitors
Table 92. Walvax Biotechnology Major Business
Table 93. Walvax Biotechnology Infant and Child Multiple Vaccine Product and Services
Table 94. Walvax Biotechnology Infant and Child Multiple Vaccine Production (M Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Walvax Biotechnology Recent Developments/Updates
Table 96. Walvax Biotechnology Competitive Strengths & Weaknesses
Table 97. Chengdu Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 98. Chengdu Institute of Biological Products Major Business
Table 99. Chengdu Institute of Biological Products Infant and Child Multiple Vaccine Product and Services
Table 100. Chengdu Institute of Biological Products Infant and Child Multiple Vaccine Production (M Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Chengdu Institute of Biological Products Recent Developments/Updates
Table 102. Minhai Biotechnology Basic Information, Manufacturing Base and Competitors
Table 103. Minhai Biotechnology Major Business
Table 104. Minhai Biotechnology Infant and Child Multiple Vaccine Product and Services
Table 105. Minhai Biotechnology Infant and Child Multiple Vaccine Production (M Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 106. Global Key Players of Infant and Child Multiple Vaccine Upstream (Raw Materials)
Table 107. Infant and Child Multiple Vaccine Typical Customers
Table 108. Infant and Child Multiple Vaccine Typical Distributors
LIST OF FIGURE
Figure 1. Infant and Child Multiple Vaccine Picture
Figure 2. World Infant and Child Multiple Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Infant and Child Multiple Vaccine Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Infant and Child Multiple Vaccine Production (2018-2029) & (M Doses)
Figure 5. World Infant and Child Multiple Vaccine Average Price (2018-2029) & (US$/Dose)
Figure 6. World Infant and Child Multiple Vaccine Production Value Market Share by Region (2018-2029)
Figure 7. World Infant and Child Multiple Vaccine Production Market Share by Region (2018-2029)
Figure 8. North America Infant and Child Multiple Vaccine Production (2018-2029) & (M Doses)
Figure 9. Europe Infant and Child Multiple Vaccine Production (2018-2029) & (M Doses)
Figure 10. China Infant and Child Multiple Vaccine Production (2018-2029) & (M Doses)
Figure 11. Japan Infant and Child Multiple Vaccine Production (2018-2029) & (M Doses)
Figure 12. Infant and Child Multiple Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Infant and Child Multiple Vaccine Consumption (2018-2029) & (M Doses)
Figure 15. World Infant and Child Multiple Vaccine Consumption Market Share by Region (2018-2029)
Figure 16. United States Infant and Child Multiple Vaccine Consumption (2018-2029) & (M Doses)
Figure 17. China Infant and Child Multiple Vaccine Consumption (2018-2029) & (M Doses)
Figure 18. Europe Infant and Child Multiple Vaccine Consumption (2018-2029) & (M Doses)
Figure 19. Japan Infant and Child Multiple Vaccine Consumption (2018-2029) & (M Doses)
Figure 20. South Korea Infant and Child Multiple Vaccine Consumption (2018-2029) & (M Doses)
Figure 21. ASEAN Infant and Child Multiple Vaccine Consumption (2018-2029) & (M Doses)
Figure 22. India Infant and Child Multiple Vaccine Consumption (2018-2029) & (M Doses)
Figure 23. Producer Shipments of Infant and Child Multiple Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Infant and Child Multiple Vaccine Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Infant and Child Multiple Vaccine Markets in 2022
Figure 26. United States VS China: Infant and Child Multiple Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Infant and Child Multiple Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Infant and Child Multiple Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Infant and Child Multiple Vaccine Production Market Share 2022
Figure 30. China Based Manufacturers Infant and Child Multiple Vaccine Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Infant and Child Multiple Vaccine Production Market Share 2022
Figure 32. World Infant and Child Multiple Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Infant and Child Multiple Vaccine Production Value Market Share by Type in 2022
Figure 34. Pentavalent Vaccine
Figure 35. Quadruple Vaccine
Figure 36. Triple Vaccine
Figure 37. Others
Figure 38. World Infant and Child Multiple Vaccine Production Market Share by Type (2018-2029)
Figure 39. World Infant and Child Multiple Vaccine Production Value Market Share by Type (2018-2029)
Figure 40. World Infant and Child Multiple Vaccine Average Price by Type (2018-2029) & (US$/Dose)
Figure 41. World Infant and Child Multiple Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 42. World Infant and Child Multiple Vaccine Production Value Market Share by Application in 2022
Figure 43. 12 Months Below
Figure 44. 12 Months Above
Figure 45. World Infant and Child Multiple Vaccine Production Market Share by Application (2018-2029)
Figure 46. World Infant and Child Multiple Vaccine Production Value Market Share by Application (2018-2029)
Figure 47. World Infant and Child Multiple Vaccine Average Price by Application (2018-2029) & (US$/Dose)
Figure 48. Infant and Child Multiple Vaccine Industry Chain
Figure 49. Infant and Child Multiple Vaccine Procurement Model
Figure 50. Infant and Child Multiple Vaccine Sales Model
Figure 51. Infant and Child Multiple Vaccine Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
Table 1. World Infant and Child Multiple Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Infant and Child Multiple Vaccine Production Value by Region (2018-2023) & (USD Million)
Table 3. World Infant and Child Multiple Vaccine Production Value by Region (2024-2029) & (USD Million)
Table 4. World Infant and Child Multiple Vaccine Production Value Market Share by Region (2018-2023)
Table 5. World Infant and Child Multiple Vaccine Production Value Market Share by Region (2024-2029)
Table 6. World Infant and Child Multiple Vaccine Production by Region (2018-2023) & (M Doses)
Table 7. World Infant and Child Multiple Vaccine Production by Region (2024-2029) & (M Doses)
Table 8. World Infant and Child Multiple Vaccine Production Market Share by Region (2018-2023)
Table 9. World Infant and Child Multiple Vaccine Production Market Share by Region (2024-2029)
Table 10. World Infant and Child Multiple Vaccine Average Price by Region (2018-2023) & (US$/Dose)
Table 11. World Infant and Child Multiple Vaccine Average Price by Region (2024-2029) & (US$/Dose)
Table 12. Infant and Child Multiple Vaccine Major Market Trends
Table 13. World Infant and Child Multiple Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (M Doses)
Table 14. World Infant and Child Multiple Vaccine Consumption by Region (2018-2023) & (M Doses)
Table 15. World Infant and Child Multiple Vaccine Consumption Forecast by Region (2024-2029) & (M Doses)
Table 16. World Infant and Child Multiple Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Infant and Child Multiple Vaccine Producers in 2022
Table 18. World Infant and Child Multiple Vaccine Production by Manufacturer (2018-2023) & (M Doses)
Table 19. Production Market Share of Key Infant and Child Multiple Vaccine Producers in 2022
Table 20. World Infant and Child Multiple Vaccine Average Price by Manufacturer (2018-2023) & (US$/Dose)
Table 21. Global Infant and Child Multiple Vaccine Company Evaluation Quadrant
Table 22. World Infant and Child Multiple Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Infant and Child Multiple Vaccine Production Site of Key Manufacturer
Table 24. Infant and Child Multiple Vaccine Market: Company Product Type Footprint
Table 25. Infant and Child Multiple Vaccine Market: Company Product Application Footprint
Table 26. Infant and Child Multiple Vaccine Competitive Factors
Table 27. Infant and Child Multiple Vaccine New Entrant and Capacity Expansion Plans
Table 28. Infant and Child Multiple Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Infant and Child Multiple Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Infant and Child Multiple Vaccine Production Comparison, (2018 & 2022 & 2029) & (M Doses)
Table 31. United States VS China Infant and Child Multiple Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (M Doses)
Table 32. United States Based Infant and Child Multiple Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Infant and Child Multiple Vaccine Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Infant and Child Multiple Vaccine Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Infant and Child Multiple Vaccine Production (2018-2023) & (M Doses)
Table 36. United States Based Manufacturers Infant and Child Multiple Vaccine Production Market Share (2018-2023)
Table 37. China Based Infant and Child Multiple Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Infant and Child Multiple Vaccine Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Infant and Child Multiple Vaccine Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Infant and Child Multiple Vaccine Production (2018-2023) & (M Doses)
Table 41. China Based Manufacturers Infant and Child Multiple Vaccine Production Market Share (2018-2023)
Table 42. Rest of World Based Infant and Child Multiple Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Infant and Child Multiple Vaccine Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Infant and Child Multiple Vaccine Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Infant and Child Multiple Vaccine Production (2018-2023) & (M Doses)
Table 46. Rest of World Based Manufacturers Infant and Child Multiple Vaccine Production Market Share (2018-2023)
Table 47. World Infant and Child Multiple Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Infant and Child Multiple Vaccine Production by Type (2018-2023) & (M Doses)
Table 49. World Infant and Child Multiple Vaccine Production by Type (2024-2029) & (M Doses)
Table 50. World Infant and Child Multiple Vaccine Production Value by Type (2018-2023) & (USD Million)
Table 51. World Infant and Child Multiple Vaccine Production Value by Type (2024-2029) & (USD Million)
Table 52. World Infant and Child Multiple Vaccine Average Price by Type (2018-2023) & (US$/Dose)
Table 53. World Infant and Child Multiple Vaccine Average Price by Type (2024-2029) & (US$/Dose)
Table 54. World Infant and Child Multiple Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Infant and Child Multiple Vaccine Production by Application (2018-2023) & (M Doses)
Table 56. World Infant and Child Multiple Vaccine Production by Application (2024-2029) & (M Doses)
Table 57. World Infant and Child Multiple Vaccine Production Value by Application (2018-2023) & (USD Million)
Table 58. World Infant and Child Multiple Vaccine Production Value by Application (2024-2029) & (USD Million)
Table 59. World Infant and Child Multiple Vaccine Average Price by Application (2018-2023) & (US$/Dose)
Table 60. World Infant and Child Multiple Vaccine Average Price by Application (2024-2029) & (US$/Dose)
Table 61. Sanofi Basic Information, Manufacturing Base and Competitors
Table 62. Sanofi Major Business
Table 63. Sanofi Infant and Child Multiple Vaccine Product and Services
Table 64. Sanofi Infant and Child Multiple Vaccine Production (M Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Sanofi Recent Developments/Updates
Table 66. Sanofi Competitive Strengths & Weaknesses
Table 67. GSK Basic Information, Manufacturing Base and Competitors
Table 68. GSK Major Business
Table 69. GSK Infant and Child Multiple Vaccine Product and Services
Table 70. GSK Infant and Child Multiple Vaccine Production (M Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. GSK Recent Developments/Updates
Table 72. GSK Competitive Strengths & Weaknesses
Table 73. Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base and Competitors
Table 74. Mitsubishi Tanabe Pharma Major Business
Table 75. Mitsubishi Tanabe Pharma Infant and Child Multiple Vaccine Product and Services
Table 76. Mitsubishi Tanabe Pharma Infant and Child Multiple Vaccine Production (M Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Mitsubishi Tanabe Pharma Recent Developments/Updates
Table 78. Mitsubishi Tanabe Pharma Competitive Strengths & Weaknesses
Table 79. KM Biologics Basic Information, Manufacturing Base and Competitors
Table 80. KM Biologics Major Business
Table 81. KM Biologics Infant and Child Multiple Vaccine Product and Services
Table 82. KM Biologics Infant and Child Multiple Vaccine Production (M Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. KM Biologics Recent Developments/Updates
Table 84. KM Biologics Competitive Strengths & Weaknesses
Table 85. Wuhan Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 86. Wuhan Institute of Biological Products Major Business
Table 87. Wuhan Institute of Biological Products Infant and Child Multiple Vaccine Product and Services
Table 88. Wuhan Institute of Biological Products Infant and Child Multiple Vaccine Production (M Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Wuhan Institute of Biological Products Recent Developments/Updates
Table 90. Wuhan Institute of Biological Products Competitive Strengths & Weaknesses
Table 91. Walvax Biotechnology Basic Information, Manufacturing Base and Competitors
Table 92. Walvax Biotechnology Major Business
Table 93. Walvax Biotechnology Infant and Child Multiple Vaccine Product and Services
Table 94. Walvax Biotechnology Infant and Child Multiple Vaccine Production (M Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Walvax Biotechnology Recent Developments/Updates
Table 96. Walvax Biotechnology Competitive Strengths & Weaknesses
Table 97. Chengdu Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 98. Chengdu Institute of Biological Products Major Business
Table 99. Chengdu Institute of Biological Products Infant and Child Multiple Vaccine Product and Services
Table 100. Chengdu Institute of Biological Products Infant and Child Multiple Vaccine Production (M Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Chengdu Institute of Biological Products Recent Developments/Updates
Table 102. Minhai Biotechnology Basic Information, Manufacturing Base and Competitors
Table 103. Minhai Biotechnology Major Business
Table 104. Minhai Biotechnology Infant and Child Multiple Vaccine Product and Services
Table 105. Minhai Biotechnology Infant and Child Multiple Vaccine Production (M Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 106. Global Key Players of Infant and Child Multiple Vaccine Upstream (Raw Materials)
Table 107. Infant and Child Multiple Vaccine Typical Customers
Table 108. Infant and Child Multiple Vaccine Typical Distributors
LIST OF FIGURE
Figure 1. Infant and Child Multiple Vaccine Picture
Figure 2. World Infant and Child Multiple Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Infant and Child Multiple Vaccine Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Infant and Child Multiple Vaccine Production (2018-2029) & (M Doses)
Figure 5. World Infant and Child Multiple Vaccine Average Price (2018-2029) & (US$/Dose)
Figure 6. World Infant and Child Multiple Vaccine Production Value Market Share by Region (2018-2029)
Figure 7. World Infant and Child Multiple Vaccine Production Market Share by Region (2018-2029)
Figure 8. North America Infant and Child Multiple Vaccine Production (2018-2029) & (M Doses)
Figure 9. Europe Infant and Child Multiple Vaccine Production (2018-2029) & (M Doses)
Figure 10. China Infant and Child Multiple Vaccine Production (2018-2029) & (M Doses)
Figure 11. Japan Infant and Child Multiple Vaccine Production (2018-2029) & (M Doses)
Figure 12. Infant and Child Multiple Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Infant and Child Multiple Vaccine Consumption (2018-2029) & (M Doses)
Figure 15. World Infant and Child Multiple Vaccine Consumption Market Share by Region (2018-2029)
Figure 16. United States Infant and Child Multiple Vaccine Consumption (2018-2029) & (M Doses)
Figure 17. China Infant and Child Multiple Vaccine Consumption (2018-2029) & (M Doses)
Figure 18. Europe Infant and Child Multiple Vaccine Consumption (2018-2029) & (M Doses)
Figure 19. Japan Infant and Child Multiple Vaccine Consumption (2018-2029) & (M Doses)
Figure 20. South Korea Infant and Child Multiple Vaccine Consumption (2018-2029) & (M Doses)
Figure 21. ASEAN Infant and Child Multiple Vaccine Consumption (2018-2029) & (M Doses)
Figure 22. India Infant and Child Multiple Vaccine Consumption (2018-2029) & (M Doses)
Figure 23. Producer Shipments of Infant and Child Multiple Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Infant and Child Multiple Vaccine Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Infant and Child Multiple Vaccine Markets in 2022
Figure 26. United States VS China: Infant and Child Multiple Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Infant and Child Multiple Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Infant and Child Multiple Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Infant and Child Multiple Vaccine Production Market Share 2022
Figure 30. China Based Manufacturers Infant and Child Multiple Vaccine Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Infant and Child Multiple Vaccine Production Market Share 2022
Figure 32. World Infant and Child Multiple Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Infant and Child Multiple Vaccine Production Value Market Share by Type in 2022
Figure 34. Pentavalent Vaccine
Figure 35. Quadruple Vaccine
Figure 36. Triple Vaccine
Figure 37. Others
Figure 38. World Infant and Child Multiple Vaccine Production Market Share by Type (2018-2029)
Figure 39. World Infant and Child Multiple Vaccine Production Value Market Share by Type (2018-2029)
Figure 40. World Infant and Child Multiple Vaccine Average Price by Type (2018-2029) & (US$/Dose)
Figure 41. World Infant and Child Multiple Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 42. World Infant and Child Multiple Vaccine Production Value Market Share by Application in 2022
Figure 43. 12 Months Below
Figure 44. 12 Months Above
Figure 45. World Infant and Child Multiple Vaccine Production Market Share by Application (2018-2029)
Figure 46. World Infant and Child Multiple Vaccine Production Value Market Share by Application (2018-2029)
Figure 47. World Infant and Child Multiple Vaccine Average Price by Application (2018-2029) & (US$/Dose)
Figure 48. Infant and Child Multiple Vaccine Industry Chain
Figure 49. Infant and Child Multiple Vaccine Procurement Model
Figure 50. Infant and Child Multiple Vaccine Sales Model
Figure 51. Infant and Child Multiple Vaccine Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
